Domino's Pizza, Inc. vs ImmunityBio Inc. Common Stock — how do they compare? Domino's Pizza, Inc. trades at $309.87 (market cap $10.21B), while ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B). The key difference: Domino's Pizza, Inc. and ImmunityBio Inc. Common Stock are close in size by market cap, and Domino's Pizza, Inc. pays a 2.58% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Domino's Pizza, Inc. for 106 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| DPZ | IBRX | |
|---|---|---|
Market Cap | $10.21B | $10.51B |
Volume | 916,737 | 10,445,785 |
Sector | Consumer Cyclical | Health |
52-Week High | $438.42 | $11.55 |
52-Week Low | $282.89 | $1.98 |
Typical Hold Time | 106 Days | 0 Days |
Enterprise Value | $15.17B | $10.97B |
Dividend Yield | 2.58% | — |
Signals from Pluang's Aura AI — not financial advice
Domino's Pizza (DPZ) trades at $303.10, showing minimal daily movement with a 0.08% gain. The stock faces technical headwinds with bearish moving averages and overbought RSI signals, while recent earnings misses and high debt levels of $5.7 billion create fundamental concerns. However, analyst sentiment remains positive with a $373 consensus price target representing 23% upside potential, supported by consistent revenue growth and strong profitability margins.
The outlook balances strong cash flow generation and market leadership against significant leverage and recent earnings disappointments. Investment opportunity exists in the valuation discount to analyst targets, but risks include debt servicing costs, competitive pressures, and execution challenges in maintaining growth momentum amid economic uncertainty.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →